Cargando…
Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer
DNA amplifications, leading to the overexpression of oncogenes, are a cardinal feature of lung cancer and directly contribute to its pathogenesis. To uncover novel such alterations, we performed an array-based comparative genomic hybridization survey of 128 non-small cell lung cancer cell lines and...
Autores principales: | Kim, Young H., Kwei, Kevin A., Girard, Luc, Salari, Keyan, Kao, Jessica, Pacyna-Gengelbach, Manuela, Wang, Pei, Hernandez-Boussard, Tina, Gazdar, Adi F., Petersen, Iver, Minna, John D., Pollack, Jonathan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320568/ https://www.ncbi.nlm.nih.gov/pubmed/19966867 http://dx.doi.org/10.1038/onc.2009.437 |
Ejemplares similares
-
Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery
por: Kao, Jessica, et al.
Publicado: (2009) -
Genomic Profiling Identifies GATA6 as a Candidate Oncogene Amplified in Pancreatobiliary Cancer
por: Kwei, Kevin A., et al.
Publicado: (2008) -
CRKL oncogene is downregulated by p53 through miR-200s
por: Tamura, Miyuki, et al.
Publicado: (2015) -
The CRKL gene encoding an adaptor protein is amplified, overexpressed, and a possible therapeutic target in gastric cancer
por: Natsume, Hiroko, et al.
Publicado: (2012) -
Crk and CrkL as Therapeutic Targets for Cancer Treatment
por: Park, Taeju
Publicado: (2021)